BPA Call 36E79726A0010-36C24526N0790
Award Date 8/2/26
Potential Completion Date 8/31/26
Potential Value $199K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38141, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for POMALYST 4 MG with a ceiling value of $16,421.95. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the Department of Veterans Affairs. Performance is located in Memphis, Tennessee. The order is firm fixed price with an ultimate completion date of May 26, 2026.</p>
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on June 18, 2026, for Pomalidomide (Pomalyst) 4 mg capsules with a ceiling value of $16,421.95. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a comprehensive master agreement covering drugs and pharmaceuticals across multiple therapeutic areas including oncology and immunology, with a contract ceiling of $12.278...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on July 31, 2026, for POMALYST 3 MG with a ceiling value of $10,887.57 under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Federal Supply Schedule. Place of performance is Memphis, Tennessee. The call carries an ultimate completion date of August 4, 2026. Pricing is firm fixed price. This order represents a narrow pharmaceutical supply call within Bristol-Myers Squibb's...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on May 27, 2026, for POMALYST 3 mg with a ceiling value of $10,887.57. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a comprehensive IDIQ vehicle covering drugs and pharmaceuticals across oncology, immunology, infectious diseases, and cardiology, with a master ceiling of $12.278 billion through April 30, 2029....
- <p>Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for Pomalidomide (Pomalyst) 4mg capsules, with a ceiling value of $16,421.95 and an ultimate completion date of May 26, 2026. The call is placed under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee. The order is firm fixed price with no set-aside designation.</p>
- The Department of Veterans Affairs Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on August 2, 2026, with a ceiling value of $51,333.17 for POMALYST 4 mg and CAMZYOS 2.5 mg, with an ultimate completion date of September 30, 2026. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Federal Supply Schedule, a multiple-award IDIQ vehicle with a $12.278 billion ceiling extending through April 30, 2029. Place of performance is Memphis,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on June 11, 2026, with a ceiling value of $16,767.72. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a multiple-award IDIQ with the VA carrying a $12.278 billion ceiling through April 30, 2029. The call procures POMALYST 2 MG, a specialty oncology pharmaceutical. Place of performance is Memphis, Tennessee. The call...
- Bristol-Myers Squibb Company was awarded a delivery order valued at $10,887.52 on April 16, 2026, for the supply of POMALYST 3 MG to Veterans Integrated Service Network 5 (VISN 5), with an ultimate completion date of April 23, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, a master schedule vehicle with a substantial ceiling...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $127,169.40 for the supply of POMALYST (pomalidomide) in 2 mg and 4 mg formulations to support the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5). This firm fixed-price contract is issued as a call against Bristol-Myers Squibb's existing Federal Supply Schedule contract (FSS-61-IB: Pharmaceuticals and Drugs) with the VA, which carries a ceiling value of $12.3 billion and extends through April...
- Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, has been awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 for the supply of Pomalyst (pomalidomide) in 2mg, 3mg, and 4mg formulations to support the Baltimore VA Medical Center. The contract is valued at $138,603.09 on a firm fixed-price basis with a completion date of May 4, 2026. This award represents a call against Bristol-Myers Squibb's existing Federal Supply...